Polar Capital Holdings PLC Eli Lilly & CO Transaction History

Polar Capital Holdings PLC

  • $16.3 Billion
  • Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Polar Capital Holdings PLC holds 97,935 shares of LLY stock, worth $77.9 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
97,935
Previous 99,212 1.29%
Holding current value
$77.9 Million
Previous $89.8 Million 3.41%
% of portfolio
0.53%
Previous 0.55%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$772.14 - $960.02 $986,022 - $1.23 Million
-1,277 Reduced 1.29%
97,935 $86.8 Million
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $13.9 Million - $17.5 Million
-19,231 Reduced 16.24%
99,212 $89.8 Million
Q1 2024

May 15, 2024
BUY
$592.2 - $792.28 $4.68 Million - $6.26 Million
7,902 Added 7.15%
118,443 $92.1 Million
Q4 2023

Feb 14, 2024
SELL
$525.19 - $619.13 $4.99 Million - $5.89 Million
-9,509 Reduced 7.92%
110,541 $64.4 Million
Q3 2023

Nov 14, 2023
SELL
$434.7 - $599.3 $7.32 Million - $10.1 Million
-16,841 Reduced 12.3%
120,050 $64.5 Million
Q2 2023

Dec 13, 2023
SELL
$350.74 - $468.98 $646,063 - $863,861
-1,842 Reduced 1.33%
136,891 $64.2 Million
Q2 2023

Aug 14, 2023
SELL
$350.74 - $468.98 $646,063 - $863,861
-1,842 Reduced 1.33%
136,891 $64.2 Million
Q1 2023

Dec 13, 2023
BUY
$310.63 - $364.82 $5.8 Million - $6.82 Million
18,683 Added 15.56%
138,733 $47.6 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $4.14 Million - $4.86 Million
-13,320 Reduced 8.76%
138,733 $47.6 Million
Q4 2022

Feb 14, 2023
BUY
$321.55 - $374.67 $12.5 Million - $14.6 Million
38,915 Added 34.4%
152,053 $55.6 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $22 Million - $25.1 Million
74,144 Added 190.14%
113,138 $36.6 Million
Q2 2022

Aug 15, 2022
SELL
$278.73 - $327.27 $1.74 Million - $2.05 Million
-6,254 Reduced 13.82%
38,994 $12.6 Million
Q1 2022

May 16, 2022
SELL
$234.69 - $291.66 $420,564 - $522,654
-1,792 Reduced 3.81%
45,248 $13 Million
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $1.9 Million - $2.34 Million
8,588 Added 22.33%
47,040 $10.9 Million
Q2 2021

Aug 16, 2021
BUY
$180.55 - $233.54 $6.94 Million - $8.98 Million
38,452 New
38,452 $8.83 Million
Q1 2021

May 17, 2021
SELL
$164.32 - $212.72 $10.7 Million - $13.8 Million
-64,908 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$130.46 - $172.63 $8.47 Million - $11.2 Million
64,908 New
64,908 $11 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email